Supply Chain Considerations for Home-Based Dosing in Decentralized Clinical Trials
Supply Chain Considerations for Home-Based Dosing in Decentralized Clinical Trials Managing Supply Chain for Home-Based Dosing in Decentralized Clinical Trials Home-based dosing is a pivotal component of Decentralized Clinical Trials (DCTs), offering convenience to participants and expanding access to remote populations. However, delivering Investigational Medicinal Products (IMPs) to patients’ homes introduces significant logistical and regulatory…
Read More “Supply Chain Considerations for Home-Based Dosing in Decentralized Clinical Trials” »